Psychoeducational intervention changes patient attitudes on clinical trials participation
Seeking ways to change cancer patients' perceptions and negative attitudes towards clinical trials participation, researchers at Moffitt Cancer Center conducted a study offering two different kinds of intervention to two groups of adults with cancer who had not previously been asked to participate in clinical trials. They found a multimedia psychoeducational intervention to be more effective in changing patients' perceptions and negative attitudes toward clinical trials than standard educational literature.
The study was published in a recent issue of the Journal of Clinical Oncology.
"Clinical trials are critical to the development of more effective cancer treatments," said study lead author Paul B. Jacobsen, Ph.D., senior member at Moffitt and associate center director for Population Science. "However, clinical trials are hampered by low rates of patient participation."
According to Jacobsen and colleagues, the low rates of patient participation point to the need to develop interventions that will increase the likelihood of patients enrolling in clinical trials. Many interventions used in the past, they noted, focused on improving the consenting process rather than changing negative attitudes about clinical trials.
"Research has consistently revealed that patients have negative perceptions and attitudes about clinical trials," explained Jacobsen. "We hypothesized that the right intervention would have a positive impact in changing perceptions and attitudes towards participation."
For this study, 472 cancer patients who had not previously been asked to participate in a clinical trial were divided into two groups: one group viewed a new, 18-minute multimedia psychoeducational presentation, and the second group received existing printed educational materials about clinical trials.
"Our results demonstrated the benefits of providing patients with a brief, multimedia psychoeducational program focused on changing attitudes towards clinical trials," wrote the researchers. "The group receiving the multimedia psychoeducational intervention developed a more positive attitude and demonstrated an increased willingness to enroll in a clinical trial when compared with the group receiving printed educational material."
"Although the effects were modest, the successful intervention has the potential to reach a large number of patients and, thus, have broad impact," wrote the researchers. "The psychoeducational multimedia presentation requires relatively little time, effort and resources to deliver."
Journal reference: Journal of Clinical Oncology
- Researchers: Quality of life as important as quantity of life Apr 27, 2012 | not rated yet | 0
- Few physicians refer patients to cancer clinical trials Feb 12, 2011 | not rated yet | 0
- Lower income cancer patients less likely to be involved in clinical trials Jun 03, 2012 | not rated yet | 0
- Penn-developed online informed consent tool could boost number of patients in cancer clinical trials Oct 03, 2011 | not rated yet | 0
- New Moffitt Cancer Center patent promises to accelerate cancer trials Feb 14, 2012 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
If you became brain-dead, would you want them to pull the plug?
16 hours ago I'd want the rest of me to stay alive. Sure it's a lousy way to live but it beats being all-the-way dead. Maybe if I make it 20 years they'll...
MRI bill question
May 15, 2013 Dear PFers, The hospital gave us a $12k bill for one MRI (head with contrast). The people I talked to at the hospital tell me that they do not...
Ratio of Hydrogen of Oxygen in Dessicated Animal Protein
May 13, 2013 As an experiment, for the past few months I've been consuming at least one portion of Jell-O or unflavored Knox gelatin per day. I'm 64, in very...
Alcohol and acetaminophen
May 13, 2013 Edit: sorry for the typo in the title , can't edit I looked around on google quite a bit and it's very hard to find precise information on the...
Marie Curie's leukemia
May 13, 2013 Does anyone know what might be the cause of Marie Curie's cancer
Genetic variations within and between populations
May 12, 2013 This paper (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1893020/) asserts these two different conclusions: ---Quote--- Thus the answer to the...
- More from Physics Forums - Medical Sciences
More news stories
(HealthDay)—Concurrent use of two immune checkpoint antibodies—ipilimumab and nivolumab—may be effective for the treatment of advanced melanoma, according to a proof-of-principal study presented in ...
Cancer 11 hours ago | not rated yet | 0
(HealthDay)—The risks of metastasis and death associated with cutaneous squamous cell carcinoma (CSCC) are low, but significant, and risk factors for poor outcome include tumor diameter, invasion beyond ...
Cancer 12 hours ago | not rated yet | 0 |
A new review finds cancer survivors suffer a diverse and complex set of impairments, affecting virtually every organ system. Writing in CA: A Cancer Journal for Clinicians, Julie Silver, M.D., associate professor at Harvar ...
Cancer 16 hours ago | not rated yet | 0
(AP)—A California doctor has been sentenced to 14 years in federal prison for bilking her patients out of more than $1 million by promising that an herbal supplement could cure late-stage cancer and other diseases.
Cancer 17 hours ago | not rated yet | 0
A new oral targeted drug, idelalisib (GS-1101), has the potential to stave off the need for additional treatments for relapsed or treatment-resistant chronic lymphocytic leukemia (CLL), according to a study led in part by ...
Cancer 18 hours ago | not rated yet | 0 |
Big names in medicine are set to give an upbeat assessment of the war on AIDS on Tuesday, 30 years after French researchers identified the virus that causes the disease.
57 minutes ago | not rated yet | 0
For combat veterans suffering from post-traumatic stress disorder, 'fear circuitry' in the brain never rests
Chronic trauma can inflict lasting damage to brain regions associated with fear and anxiety. Previous imaging studies of people with post-traumatic stress disorder, or PTSD, have shown that these brain regions can over-or ...
1 hour ago | not rated yet | 0 |
The neural machinery underlying our olfactory sense continues to be an enigma for neuroscience. A recent review in Neuron seeks to expand traditional ideas about how neurons in the olfactory bulb might encode information about ...
12 hours ago | not rated yet | 0 |
(Medical Xpress)—What if the quality of your work depends more on your focus on the piano keys or canvas or laptop than your musical or painting or computing skills? If target users can be convinced, they ...
13 hours ago | 3.7 / 5 (3) | 0 |
In 2008 researchers from the University of Southern Denmark showed that the drug thioridazine, which has previously been used to treat schizophrenia, is also a powerful weapon against antibiotic-resistant bacteria such as ...
10 hours ago | 3.7 / 5 (3) | 0 |
(Medical Xpress)—Working with lab mice models of multiple sclerosis (MS), UC Davis scientists have detected a novel molecular target for the design of drugs that could be safer and more effective than current FDA-approved ...
10 hours ago | 5 / 5 (2) | 0 |